Goldman Sachs Group Inc Syneos Health, Inc. Transaction History

Goldman Sachs Group Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 14, 2024	SELL	$34.5 - $42.19 $4.89 Million - $5.98 Million	-141,843 Reduced 17.02%	691,432 $29.1 Million
Q2 2023 Aug 14, 2023	SELL	$34.5 - $42.19 $4.89 Million - $5.98 Million	-141,843 Reduced 17.02%	691,432 $29.1 Million
Q1 2023 May 14, 2024	SELL	$33.32 - $40.98 $102 Million - $125 Million	-3,046,327 Reduced 78.52%	833,275 $29.7 Million
Q1 2023 May 11, 2023	SELL	$33.32 - $40.98 $102 Million - $125 Million	-3,046,327 Reduced 78.52%	833,275 $29.7 Million
Q4 2022 May 14, 2024	BUY	$25.32 - $51.45 $80.1 Million - $163 Million	3,164,772 Added 442.73%	3,879,602 $142 Million
Q4 2022 Feb 13, 2023	BUY	$25.32 - $51.45 $80.1 Million - $163 Million	3,164,772 Added 442.73%	3,879,602 $142 Million
Q3 2022 May 14, 2024	BUY	$46.5 - $79.14 $3.32 Million - $5.66 Million	71,456 Added 11.11%	714,830 $33.7 Million
Q3 2022 Nov 10, 2022	BUY	$46.5 - $79.14 $3.32 Million - $5.66 Million	71,456 Added 11.11%	714,830 $33.7 Million
Q2 2022 May 14, 2024	BUY	$63.06 - $84.75 $40.6 Million - $54.5 Million	643,374 New	643,374 $46.1 Million
Q2 2022 Aug 15, 2022	SELL	$63.06 - $84.75 $2.92 Million - $3.92 Million	-46,278 Reduced 6.71%	643,374 $46.1 Million
Q1 2022 May 16, 2022	BUY	$74.15 - $99.36 $15.3 Million - $20.6 Million	206,914 Added 42.86%	689,652 $55.8 Million
Q4 2021 Feb 14, 2022	SELL	$86.01 - $102.89 $4.28 Million - $5.12 Million	-49,723 Reduced 9.34%	482,738 $49.6 Million
Q3 2021 Nov 10, 2021	BUY	$84.7 - $96.31 $45.1 Million - $51.3 Million	532,461 New	532,461 $46.6 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.